Lung Cancer


 

 
LRRI offers research and development capabilities for investigating the causes, mechanisms, and detection of lung cancer, genetic susceptibility, and interspecies differences in carcinogenesis.
 

 

LRRI scientists are recognized internationally for their integration of research using animal models, human lung tumors, primary human and animal cell cultures and cell lines, and contemporary molecular and cell biology techniques to study lung cancer mechanisms, risk, and interventions.

In addition to independent research, LRRI has broad experience in collaborating with epidemiologists and laboratory researchers in industry and academia.

Key Capabilities:

  • Interspecies extrapolation of genetic aberrations in premalignant and malignant cells
  • Novel human and rodent cell, tissue, and tissue-equivalent models for carcinogen exposures
  • Full spectrum of investigative tools, including PCR and immunohistochemistry
  • Access to human populations known to be at high risk
  • Wide range of short-term genetic damage assays
  • Genotoxic biomarkers to detect ongoing carcinogenesis in animals and humans

In Addition

  • Compliance with Institutional Review Board procedures, Good Laboratory Practice regulations, and other customer requirements
  • Confidentiality, proprietary, and intellectual property agreements

In addition to independent research, LRRI has broad experience in collaborating with epidemiologists and laboratory researchers in industry and academia.

 

ACCESS LRRI PUBLICATIONS ON THIS TOPIC IN PUBMED